Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Comprehensive analysis of the clinical and biological significances for chemokine CXCL3 in cholangiocarcinoma
Hong‐Yue Ren, Xiaofan Yang, Wenrong Hou, et al.
Medicine (2024) Vol. 103, Iss. 11, pp. e37460-e37460
Open Access | Times Cited: 2
Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion
Satoshi Kawano, Megumi Ikemori Kawada, Sayo Fukushima, et al.
Anticancer Research (2024) Vol. 44, Iss. 6, pp. 2393-2406
Open Access | Times Cited: 2
ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling
Fangfeng Liu, Qianchang Wang, Zhengjian Wang, et al.
Translational Oncology (2024) Vol. 47, pp. 102035-102035
Open Access | Times Cited: 2
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression
Ziwei Liang, Yang Ge, Li Jianjian, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 2
Development and in vitro evaluation of ursolic acid-loaded poly(lactic-co-glycolic acid) nanoparticles in cholangiocarcinoma
Pornpattra Maphanao, Yaowaret Phothikul, Cherdpong Choodet, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24828-24837
Open Access | Times Cited: 2
Conversion therapy in advanced perihilar cholangiocarcinoma based on patient-derived organoids: A case report
Yonggang He, Lingyu Zhang, Jing Li, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 10, pp. 4274-4280
Closed Access | Times Cited: 2
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 2613-2624
Open Access | Times Cited: 6
Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer
Natalia Piekuś-Słomka, Lavinia Patricia Mocan, Rezarta Shkreli, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5100-5100
Open Access | Times Cited: 5
Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma by ultrasonography combined with multiphase enhanced computed tomography
HaiYing Tian, Yuling Chen, X.-P. Li, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3362-3369
Open Access | Times Cited: 1
Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
Jia-yan Ni, Hongliang Sun, Ge-Fan Guo, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112872-112872
Closed Access | Times Cited: 1
Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology
Inyoung Cheon, Minwook Kim, Kang Ho Kim, et al.
American Journal Of Pathology (2024)
Open Access | Times Cited: 1
Influence of Perineural (Pn), Lymphangio (L) and Vascular (V) Invasion on Survival after Resection of Perihilar Cholangiocarcinoma
Rabea Margies, Lisa-Katharina Gröger, Beate K. Straub, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3463-3463
Open Access | Times Cited: 1
Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation
Hong‐Wen Liu, Lei Xu, Yiyang Zhang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Closed Access | Times Cited: 4
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 26-26
Open Access | Times Cited: 4
Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment
Fei Pei, Tao Zhen, Lu Qi, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma in patients aged 60 and older: a retrospective cohort study
Jianlei Wang, Wei Wang, Xiaolei Chen, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study
Zhongquan Sun, Xin Han, Wanlu You, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Model-based cost-utility analysis of gemcitabine, cisplatin, and S-1 as triple therapy for advanced biliary tract cancer
Munenobu Kashiwa, Ryo Matsushita
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 4, pp. 875-883
Open Access | Times Cited: 3
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression
Antonio Cigliano, Alastair J. Strain, Massimiliano Cadamuro
Hepatoma Research (2023) Vol. 9, Iss. 14, pp. 14-14
Open Access | Times Cited: 3
Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Haneyeh Shahbazian, Mohammad Mirza‐Aghazadeh‐Attari, Ali Borhani, et al.
Journal of Surgical Oncology (2023) Vol. 128, Iss. 4, pp. 519-530
Closed Access | Times Cited: 2
Identification of Cholangiocarcinoma (CCA) Subtype-Specific Biomarkers
Jacob Croft, Liyuan Gao, Odalys Quintanar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Systematic sequential therapy for ex vivo liver resection and autotransplantation: A case report and review of literature
Chenlu Hu, Xin Han, Zhen-Zhen Gao, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 11, pp. 2663-2673
Open Access | Times Cited: 2
The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma
Chiyu Cai, Lianyuan Tao, Dongxiao Li, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 3, pp. 333-343
Closed Access | Times Cited: 2
Prognostic model for oversurvival and tumor-specific survival prediction in patients with advanced extrahepatic cholangiocarcinoma: a population-based analysis
Yu Zhang, Chunzhong Qiao, Peng Zhao, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Establishment and validation of a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with perineural invasion.
Maobing Wang, Zhaowei Sun, Qinlei Wang, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5082-5093
Closed Access | Times Cited: 2

Scroll to top